This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 1977
Title: The Innovative Contributions of Klaus Kieslich
Introduction: Klaus Kieslich is a distinguished inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on D-homosteroids. With one patent to his name, Kieslich's research reflects his commitment to developing new solutions for anti-inflammatory treatments.
Latest Patents: Klaus Kieslich holds a patent for novel D-homosteroids. This invention showcases compounds with the formula ##STR1##, which are noted for their anti-inflammatory activity. The D-homosteroids developed by Kieslich are not only groundbreaking in their therapeutic potential but also serve as useful intermediates for the synthesis of further anti-inflammatory D-homosteroids. This patent represents a significant step forward in pharmaceutical research.
Career Highlights: Throughout his career, Klaus has focused on the synthesis and application of novel compounds in the biomedical field. His work has garnered attention for its innovative approach to combating inflammation, which is a critical area in the development of new medications. The depth of his research exemplifies his dedication to advancing scientific knowledge and improving patient outcomes.
Collaborations: In his professional journey, Klaus has collaborated with talented individuals such as Andor Furst and Marcel Muller. Working alongside these professionals has allowed him to leverage a range of expertise, fostering a collaborative environment that nurtures innovation and accelerates the development of new ideas.
Conclusion: Klaus Kieslich's contributions to the field of anti-inflammatory compounds underscore his importance as an inventor in modern science. His patent on D-homosteroids not only highlights his innovative spirit but also promises to make a lasting impact on the pharmaceutical industry. As research continues to evolve, Kieslich's work serves as a foundation for future advancements in the management of inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile